Our U.S. operations include research and development centers that conduct leading-edge work in advancing disease detection and treatment. Our diagnostics and pharmaceuticals businesses in the U.S. employ some 26,000 people and generate close to $16 billion in sales, accounting for about one-third of the Roche Group's global annual revenues.